# Prospective Evaluation of the Radiographic Efficacy of Enbrel

> **NCT01623752** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1821 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Psoriasis Arthritis

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT01623752
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 1821 (ACTUAL)
- **Last updated:** 2019-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623752, "Prospective Evaluation of the Radiographic Efficacy of Enbrel". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01623752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*